Product Images Dexlansoprazole Delayed Release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Dexlansoprazole Delayed Release NDC 24979-704 by Twi Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a graph that shows the plasma concentration (in ng/mL) of DEXLANSOPRAZOLE at two different dosages (30mg and 60mg) over a period of 20 hours. The concentration levels for each dosage start at approximately 1200 ng/mL and gradually decrease over time. The graph also includes a time scale on the x-axis, indicating the elapsed time in hours from the start of the study.*
This is the information found on a medication package for Dexlansoprazole capsules, including dosage instructions and storage requirements. It also warns not to accept the package if the seal is broken or missing. The medication is manufactured by TWi Pharmaceuticals USA, Inc.*
This is a medication for which the usual dosage can be found in the package insert. The medication is Dexlansoprazole and each blue capsule features delayed-release 60 mg of the medication. It is important to ensure that the seal of the bottle is intact. The medication should be stored between 20 and 25°C (68 to 77°F), with excursions permitted to 30°C (59 to 86°F). It is only available with a prescription and has been manufactured for TWi Pharmaceuticals USA. The GTIN code for the medication is 00324979704067, and a pack consists of 30 capsules.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.